COMPANY PROFILE // THE 014 REPORT
QHSLab, Inc.
USAQ (OTC) · Formerly: USA EQUITIES CORP.; AMERICAN BIOGENETIC SCIENCES INC
Assembled from 2 government sources in 2.6 s
FLAGS · DISCLOSURE · SUMMARY
Missing or hidden
No flag from the records checked. 26 of 26 lists and sources checked came back clear (panel below).
✓ SEC filings✗ LEI✗ SAM registration✗ IRS return✗ State registration✗ Website✗ Lobbying registration
No LEI, no SAM registration, no IRS return, no state registration, no website, no lobbying registration on record.
QHSLab, Inc. is an SEC-registered operating company in surgical & medical instruments & apparatus, incorporated in NV, based in West Palm Beach, FL; listed as USAQ (OTC).[source] It reported revenue of $2.7 million for the fiscal year ended 2025-12-31.[source] It has filed 28 documents with the SEC in the last 12 months; the latest is Form 10-Q, filed 2026-11-12.[source] Every list and source checked for this page came back clear (26 of 26), dated in the checks panel.[source]
- red0
- amber0
- info0
- CLEAR26
- POSSIBLE MATCH0
- MATCH0
RECORD · WEB
Ask about this entity
Answers come from this 014 first; every line is marked RECORD (our record, linked) or WEB (a web page, credited and linked).
PEOPLE · COUNSEL · LINKS
Leadership, advisers and links
Officers and directors (Forms 3, 4, 5)
- Grogan Troy James · President and CEO (Director,Officer,10% owner) · latest Form 5 2026-02-13 · filing · LinkedIn search
As reported to the SEC by the insiders themselves; SEC insider transactions data sets (Forms 3, 4, 5): 2026q1, 2025q4, 2025q3, 2025q2.
Legal counsel, as publicly named
- Mandelbaum Salsburg P.C. · Exhibit 5.1 legal opinion, S-8 filed 2020-03-11
EVERY LIST AND SOURCE · DATED
Checked and clear
26 lists and sources checked: 26 CLEAR, 0 POSSIBLE MATCH, 0 MATCH. Screening lists are checked when this 014 is built; the enforcement and registry sources at the last company-engine build. Each date is the date of that check.
EVERY IDENTIFIER · LINKED
ID crosswalk
| Identifier | Value | Record |
|---|---|---|
| SEC CIK | 0000856984 | source |
| EIN | 11-2655906 | source |
| Business address (SEC) | 901 NORTHPOINT PARKWAY, WEST PALM BEACH, FL, 33407 | source |
Does not exist in the records we hold: LEI, UEI, NY DOS ID, FDIC certificate.
EACH FEEDS WATCH
Dates coming up
- 2027-03-31 · in 130 days · Next 10-K due (period ended 2026-12-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
- 2027-05-15 · in 175 days · Next 10-Q due (period ended 2027-03-31; Non-accelerated filer<br>Smaller reporting company) (computed from the fiscal year end and filer status)
PEERS BY SIC CODE
Industry context
SIC 3841 (surgical & medical instruments & apparatus): 149 companies in our records share this code.
federal dollars
lobbying filings
SEC filings in 12 months
flags
Peers, each with its 014
- STRYKER CORP · 101 SEC filings in 12 months · 1 flag · $502.2M federal (possible match)
- ORASURE TECHNOLOGIES INC · 69 SEC filings in 12 months · 2 flags · $480.7M federal (possible match)
- 3M CO · 124 SEC filings in 12 months · $465.5M federal (possible match)
- BOSTON SCIENTIFIC CORP · 110 SEC filings in 12 months · 1 flag · $140.1M federal (possible match)
- CERUS CORP · 71 SEC filings in 12 months · 2 flags · $126.6M federal (possible match)
- BAXTER INTERNATIONAL INC · 84 SEC filings in 12 months · 1 flag · $54.7M federal (possible match)
- Inspire Medical Systems, Inc. · 100 SEC filings in 12 months · 4 flags · $22.3M federal (possible match)
- ACCURAY INC · 103 SEC filings in 12 months · 4 flags · $13.9M federal (possible match)
- NeuroPace Inc · 61 SEC filings in 12 months · $10.3M federal (possible match)
- TELEFLEX INC · 64 SEC filings in 12 months · 1 flag · $9.4M federal (possible match)
- Cytosorbents Corp · 30 SEC filings in 12 months · 4 flags · $5.0M federal (possible match)
- IRADIMED CORP · 70 SEC filings in 12 months · 1 flag · $4.0M federal (possible match)
EVERY SOURCE · NEWEST FIRST
One timeline
- 2026-11-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-09-04 filing SCHEDULE 13D/A · SEC EDGAR
- 2026-08-12 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-08-03 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-06-17 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-26 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-05-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2026-04-27 filing SCHEDULE 13D · SEC EDGAR
- 2026-04-21 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-03-31 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-03-30 filing Annual report (10-K) · SEC EDGAR
- 2026-02-13 insider First Form 3/4/5 on record for Grogan Troy James (President and CEO) · SEC Forms 3/4/5
- 2026-01-26 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-01-23 filing 8-K items 1.01,3.02,8.01,9.01 · SEC EDGAR
- 2026-01-16 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-01-06 filing D · SEC EDGAR
- 2026-01-06 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2026-01-02 filing 8-K items 1.01,3.02,9.01 · SEC EDGAR
- 2025-12-29 filing 8-K items 1.01,3.02,7.01,9.01 · SEC EDGAR
- 2025-12-03 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-12-01 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-11-24 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-11-18 filing 8-K items 1.01,2.04,7.01,9.01 · SEC EDGAR
- 2025-11-13 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-09-02 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-08-14 filing Quarterly report (10-Q) · SEC EDGAR
- 2025-07-08 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-06-03 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-05-21 filing 8-K items 7.01,9.01 · SEC EDGAR
- 2025-05-16 filing 8-K items 7.01,9.01 · SEC EDGAR
170 earlier entries
- 2025-05-15 filing 8-K items 7.01,9.01
- 2025-05-14 filing Quarterly report (10-Q)
- 2025-03-28 filing Annual report (10-K)
- 2025-02-26 filing 8-K items 7.01,9.01
- 2025-02-25 filing 8-K items 2.04,9.01
- 2025-02-18 filing 8-K items 7.01,9.01
- 2025-02-11 filing 8-K items 7.01,9.01
- 2025-01-21 filing 8-K items 7.01,9.01
- 2025-01-16 filing 8-K items 7.01,9.01
- 2024-12-16 filing 8-K items 7.01,9.01
- 2024-12-13 filing 8-K items 7.01,9.01
- 2024-11-25 filing 8-K items 7.01,9.01
- 2024-11-14 filing 8-K items 7.01,9.01
- 2024-11-13 filing Quarterly report (10-Q)
- 2024-10-22 filing 8-K items 1.01,3.02,7.01,9.01
- 2024-10-21 filing 8-K items 7.01,9.01
- 2024-09-25 filing 8-K items 7.01,9.01
- 2024-09-17 filing 8-K items 7.01,9.01
- 2024-08-14 filing 8-K items 7.01,9.01
- 2024-08-14 filing Quarterly report (10-Q)
- 2024-06-07 filing 8-K items 4.01,9.01
- 2024-05-13 filing 8-K items 7.01,9.01
- 2024-05-13 filing Quarterly report (10-Q)
- 2024-05-02 filing 8-K items 7.01,9.01
- 2024-04-26 filing 8-K items 7.01,9.01
- 2024-04-18 filing 8-K items 7.01,9.01
- 2024-03-28 filing 8-K items 7.01,9.01
- 2024-03-27 filing Annual report (10-K)
- 2024-01-30 filing 8-K items 7.01,9.01
- 2023-11-13 filing Quarterly report (10-Q)
- 2023-10-25 filing 8-K items 7.01,9.01
- 2023-10-18 filing 8-K items 7.01,9.01
- 2023-10-06 filing 8-K items 1.01,9.01
- 2023-08-10 filing Quarterly report (10-Q)
- 2023-05-15 filing 8-K items 7.01,9.01
- 2023-05-12 filing Quarterly report (10-Q)
- 2023-03-29 filing Annual report (10-K)
- 2023-02-16 filing 8-K items 7.01,9.01
- 2023-01-30 filing 8-K items 7.01,9.01
- 2022-11-14 filing 8-K items 7.01,9.01
- 2022-11-14 filing Quarterly report (10-Q)
- 2022-11-01 filing 8-K items 7.01,9.01
- 2022-10-07 filing 424B3
- 2022-10-05 filing EFFECT
- 2022-10-03 filing CORRESP
- 2022-09-30 filing UPLOAD
- 2022-09-27 filing Registration (S-1)
- 2022-09-20 filing 8-K items 7.01,9.01
- 2022-08-15 filing Quarterly report (10-Q)
- 2022-07-29 filing 8-K items 1.01,3.02,9.01
- 2022-05-24 filing 8-K items 7.01,9.01
- 2022-05-16 filing Quarterly report (10-Q)
- 2022-05-09 filing 8-K items 7.01,9.01
- 2022-04-19 filing 8-K items 5.03,7.01,9.01
- 2022-04-19 name change Name changed from USA EQUITIES CORP.
- 2022-04-05 filing 8-K items 7.01,9.01
- 2022-04-01 filing Annual report (10-K)
- 2022-04-01 filing NT 10-K
- 2022-01-18 filing DEF 14C
- 2021-12-30 filing 8-K items 1.01,3.02,3.03,4.01,5.03,9.01
- 2021-12-21 filing PRE 14C
- 2021-11-16 filing 8-K items 7.01,9.01
- 2021-11-15 filing Quarterly report (10-Q)
- 2021-10-28 filing 424B3
- 2021-10-27 filing 8-K items 1.01,3.03,5.03,9.01
- 2021-09-22 filing 8-K items 7.01,9.01
- 2021-09-21 filing 424B3
- 2021-09-16 filing EFFECT
- 2021-09-14 filing CORRESP
- 2021-09-13 filing S-1/A
- 2021-09-10 filing UPLOAD
- 2021-09-03 filing Registration (S-1)
- 2021-08-17 filing 8-K items 7.01,9.01
- 2021-08-16 filing Quarterly report (10-Q)
- 2021-08-05 filing 8-K items 7.01,9.01
- 2021-07-15 filing 8-K items 7.01,9.01
- 2021-06-29 filing 8-K items 7.01,9.01
- 2021-06-24 filing 8-K items 1.01,2.01,3.02,7.01
- 2021-06-21 filing DEF 14C
- 2021-06-09 filing 8-K items 7.01,9.01
- 2021-06-07 filing PRE 14C
- 2021-05-27 filing 8-K items 7.01,9.01
- 2021-05-18 filing 8-K items 7.01,9.01
- 2021-05-17 filing Quarterly report (10-Q)
- 2021-05-13 filing 8-K items 7.01,9.01
- 2021-03-26 filing 8-K items 1.01,8.01,9.01
- 2021-03-11 filing Annual report (10-K)
- 2021-02-23 filing 8-K items 7.01,9.01
- 2021-02-19 filing 8-K items 7.01,9.01
- 2021-02-17 filing 8-K items 7.01,9.01
- 2020-12-30 filing 8-K items 7.01,9.01
- 2020-12-10 filing 8-K items 7.01,9.01
- 2020-11-23 filing 8-K items 7.01,9.01
- 2020-11-13 filing 8-K items 7.01,9.01
- 2020-11-12 filing Quarterly report (10-Q)
- 2020-10-26 filing 8-K items 1.01,7.01,9.01
- 2020-10-09 filing 8-K items 7.01,9.01
- 2020-09-30 filing 8-K items 7.01,9.01
- 2020-09-30 filing 8-K items 1.01,2.03,3.02,9.01
- 2020-09-25 filing 8-K items 1.01,2.03,3.02,9.01
- 2020-09-25 filing D
- 2020-09-14 filing 8-K items 7.01,9.01
- 2020-09-01 filing 8-K items 7.01,9.01
- 2020-08-24 filing 8-K items 1.01,3.02,7.01,9.01
- 2020-08-13 filing Quarterly report (10-Q)
- 2020-06-30 filing 8-K items 8.01,9.01
- 2020-05-14 filing Quarterly report (10-Q)
- 2020-04-22 filing 8-K items 1.01,3.02,9.01
- 2020-03-17 filing 8-K items 7.01,8.01,9.01
- 2020-03-13 filing 8-K items 1.01,9.01
- 2020-03-11 filing S-8
- 2020-02-27 filing 8-K items 1.01,2.03
- 2020-02-21 filing Annual report (10-K)
- 2020-02-19 filing 8-K/A items 2.01,9.01
- 2019-12-23 filing 8-K items 1.01,2.01,3.02,4.01,5.01,5.06,9.01
- 2019-11-12 filing Quarterly report (10-Q)
- 2019-09-05 filing 8-K items 1.01,3.02
- 2019-08-05 filing Quarterly report (10-Q)
- 2019-05-14 filing Quarterly report (10-Q)
- 2019-03-28 filing Annual report (10-K)
- 2019-02-20 filing 8-K items 4.01,9.01
- 2018-10-29 filing Quarterly report (10-Q)
- 2018-09-10 filing Quarterly report (10-Q)
- 2018-08-29 filing Quarterly report (10-Q)
- 2018-08-27 filing Annual report (10-K)
- 2018-08-22 filing Quarterly report (10-Q)
- 2018-08-20 filing Quarterly report (10-Q)
- 2018-08-17 filing Quarterly report (10-Q)
- 2018-08-07 filing Annual report (10-K)
- 2018-07-20 filing Quarterly report (10-Q)
- 2018-07-16 filing Quarterly report (10-Q)
- 2018-06-29 filing 8-K items 4.01,9.01
- 2016-08-12 filing NT 10-Q
- 2016-05-26 filing Quarterly report (10-Q)
- 2016-05-16 filing NT 10-Q
- 2016-04-14 filing Annual report (10-K)
- 2016-03-30 filing NT 10-K
- 2015-11-23 filing Quarterly report (10-Q)
- 2015-11-16 filing NT 10-Q
- 2015-11-16 name change Name changed from AMERICAN BIOGENETIC SCIENCES INC
- 2015-08-19 filing Quarterly report (10-Q)
- 2015-08-14 filing NT 10-Q
- 2015-08-04 filing 8-K items 1.01,3.02,9.01
- 2015-06-12 filing DEF 14C
- 2015-06-01 filing PRE 14C
- 2015-05-27 officer change 8-K items 5.02
- 2015-05-14 filing Quarterly report (10-Q)
- 2015-04-07 filing Annual report (10-K)
- 2015-03-31 filing NT 10-K
- 2014-11-14 filing Quarterly report (10-Q)
- 2014-08-19 filing Quarterly report (10-Q)
- 2014-08-14 filing NT 10-Q
- 2014-05-12 filing Quarterly report (10-Q)
- 2014-05-12 filing Annual report (10-K)
- 2014-04-14 filing Quarterly report (10-Q)
- 2014-04-14 filing Quarterly report (10-Q)
- 2014-04-14 filing Quarterly report (10-Q)
- 2014-02-26 filing Annual report (10-K)
- 2014-01-31 filing Quarterly report (10-Q)
- 2012-11-13 filing NT 10-Q
- 2012-09-27 filing Quarterly report (10-Q)
- 2012-08-14 filing NT 10-Q
- 2012-05-21 filing Quarterly report (10-Q)
- 2012-05-14 filing NT 10-Q
- 2012-04-12 filing Annual report (10-K)
- 2012-03-29 filing NT 10-K
- 2011-11-14 filing Quarterly report (10-Q)
- 2011-09-22 filing 8-K items 1.01,9.01
- 2011-08-24 filing Quarterly report (10-Q)
- 2011-08-15 filing NT 10-Q
RENDERED FROM THIS PAGE
Relationship graph
Holders from 13F filings, subsidiaries from the GLEIF tree (by LEI), lobbying firms from LDA (possible match), agencies from USAspending, people from Forms 3/4/5, counsel from Exhibit 5.1, shared boards from Forms 3/4/5.
DATA MOTION // NEWEST FIRSTWhat changed
- 2026-11-12 (within 30 days) 10-Q filed
- 2026-08-12 (older) 10-Q filed
- 2026-08-03 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-17 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-26 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-14 (older) 10-Q filed
- 2026-04-21 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-03-31 (older) 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
Dot rule: red = within 7 days, amber = within 30 days, green = older. Measured against 2026-11-22; the colour is also written out in words.
PRICE · FILINGS · POSTS · NEWSMarket & news
- Price
- No listing symbol is held for this company.
- Open in
Open in…
Price and chart
News
Analyst estimates and earnings
Institutional holders
Short interest
Official social
Each link opens the other site in a new tab, with this company filled in. That site shows its own data under its own terms; Seraphix stores none of it. Seraphix counts clicks per link, nothing about who clicked.
- Financials
- Filed figures: published SEC values, each linked to its filing.
- Official posts
- Links to posts from the company's and agencies' verified accounts: not connected yet.
- News
- Article links (headline, date, link): not connected yet.
EVERY RESOLVED IDENTIFIER1. Identity
1 possible match held apart, matched by name only, not counted above; 1 record under a former name, shown apart.
| Identifier | Value | How it was resolved | Source |
|---|---|---|---|
| SEC CIK | 856984 | id:sec-anchor: the SEC registrant record of this company | SEC EDGAR |
| Ticker / exchange | USAQ / OTC | SEC company record: ticker and exchange as listed on the SEC company record | SEC EDGAR |
| EIN | 112655906 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000856984 | SEC EDGAR / IRS |
| CUSIP | 90350R107 | carried on the SEC-anchored record: listed in the identifiers of sx:sec:0000856984 | SEC EDGAR |
former name (shown apart, not merged) (1)
- former nameAMERICAN BIOGENETIC SCIENCES · EPA ECHO facilities
AS FILED · EACH WITH ITS DATE AND FILING2. Filed figures
Key figures (annual filing)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Revenue (fiscal year ended 2025-12-31) | $2,691,741 | 2025-12-31 | 10-K, XBRL RevenueFromContractWithCustomerExcludingAssessedTax | as filed | 2026-11-22 09:20 UTC | Report an error |
| Net income (loss) (fiscal year ended 2025-12-31) | $457,417 | 2025-12-31 | 10-K, XBRL NetIncomeLoss | as filed | 2026-11-22 09:20 UTC | Report an error |
| Total assets (at 2025-12-31) | $2,171,006 | 2025-12-31 | 10-K, XBRL Assets | as filed | 2026-11-22 09:20 UTC | Report an error |
| Stockholders' equity (at 2025-12-31) | $1,624,928 | 2025-12-31 | 10-K, XBRL StockholdersEquity | as filed | 2026-11-22 09:20 UTC | Report an error |
| Cash and cash equivalents (at 2025-12-31) | $636,157 | 2025-12-31 | 10-K, XBRL CashAndCashEquivalentsAtCarryingValue | as filed | 2026-11-22 09:20 UTC | Report an error |
Company profile facts (SEC)
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| SEC entity type | operating | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
| SIC industry | 3841 Surgical & Medical Instruments & Apparatus | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
| State of incorporation | NV | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
| Fiscal year end (MMDD) | 1231 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
| Business address | 901 NORTHPOINT PARKWAY, SUITE 302, WEST PALM BEACH, FL, 33407 | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
| Exchanges | OTC | 2026-11-12 | SEC EDGAR company profile | as filed | 2026-11-22 09:20 UTC | Report an error |
Other filed values
| Figure | Value | Period or as of | Source | Basis | Retrieved | Report |
|---|---|---|---|---|---|---|
| Operating cash flow (fiscal year ended 2025-12-31) | $178,118 | 2025-12-31 | 10-K, XBRL NetCashProvidedByUsedInOperatingActivities | as filed | 2026-11-22 09:20 UTC | Report an error |
| Form D total offering amount (D filed 2026-01-06) | $700,000 | 2026-01-06 | D | as filed | 2026-11-22 09:20 UTC | Report an error |
| Form D total amount sold (D filed 2026-01-06) | $626,548 | 2026-01-06 | D | as filed | 2026-11-22 09:20 UTC | Report an error |
| Form D industry group | Other Health Care | 2026-01-06 | D | as filed | 2026-11-22 09:20 UTC | Report an error |
| Form D revenue range | Decline to Disclose | 2026-01-06 | D | as filed | 2026-11-22 09:20 UTC | Report an error |
| Form D date of first sale | 2025-12-26 | 2026-01-06 | D | as filed | 2026-11-22 09:20 UTC | Report an error |
Latest report: 10-Q for the period ended 2026-09-30, filed 2026-11-12 · accession 0001493152-26-051468
| Item | Value | Period | Form | Filed | Accession | Retrieved | Report |
|---|---|---|---|---|---|---|---|
| Revenue | $677,172 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051468 | 2026-11-22 09:20 UTC | Report an error |
| Net income (loss) | -$53,145 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051468 | 2026-11-22 09:20 UTC | Report an error |
| Interest expense | $2,741 | 3 months ended 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051468 | 2026-11-22 09:20 UTC | Report an error |
| Cash and cash equivalents | $190,464 | at 2026-09-30 | 10-Q | 2026-11-12 | 0001493152-26-051468 | 2026-11-22 09:20 UTC | Report an error |
Values as filed in XBRL (SEC company facts); quarterly values are the filer's own 3-month figures, never derived.
No estimates: every value is as filed and links to the filing it came from.
Registration: the SEC filer status is under "Company profile facts (SEC)" above. SAM.gov registration status: not held yet.
NEWEST FIRST · EACH LINKS TO ITS FILING3. Registration and filing timeline
- 2026-11-12 Filing 10-Q filed
- 2026-08-12 Filing 10-Q filed
- 2026-08-03 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-06-17 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-26 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-05-14 Filing 10-Q filed
- 2026-04-21 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-03-31 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-03-30 Filing 10-K filed
- 2026-01-26 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-01-23 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 8.01 other event; Item 9.01 exhibits
- 2026-01-16 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-01-06 Filing D filed
- 2026-01-06 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2026-01-02 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 9.01 exhibits
- 2025-12-29 Filing 8-K filed: Item 1.01 material agreement; Item 3.02 unregistered equity sale; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-12-03 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-12-01 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-24 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-18 Filing 8-K filed: Item 1.01 material agreement; Item 2.04; Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-11-13 Filing 10-Q filed
- 2025-09-02 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-08-14 Filing 10-Q filed
- 2025-07-08 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
- 2025-06-03 Filing 8-K filed: Item 7.01 Regulation FD disclosure; Item 9.01 exhibits
POSSIBLE MATCHES · LICENCES, PERMITS, CITY AND STATE RECORDS13. Permits and local records
1 state and city record carry this company's exact name, from 1 source. Possible matches only.
ClinicalTrials.gov (1)
possible match: matched by name only, not merged (1)
Possible match based on name, not a shared identifier. Compare the records.
- possible matchQHSLab, Inc. · exact legal name · sx:ctgov:heea1e87fd91b5225 Compare
WHAT THIS PAGE READ
Sources
JSON · MCP · API
API and agents
The same profile as JSON: GET /company/856984.json. The MCP server and the records API return the same data: GET /v1/record/sx:sec:0000856984. Every source URL used is listed in the file.
Get the evidence file, alerts and the API with a free key. Everything on this page stays free to read.